# EverEdge Global

headquartered in New Zealand, publishes valuation models spanning ten distinct IP asset classes relevant to pharmaceutical and biotech portfolios.


Source: https://cn.bioecon.ru/companies/everedge-global/
Updated: 2026-08-16

- 国家: NZ

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 未注明来源的风险投资及与投资方(包括Punakaiki Fund)签订的股份购买协议;部分来源称未募集任何资金 [中等置信度] | https://prospeo.io/c/everedge-global-revenue, https://www.nbr.co.nz/shoeshine/the-rise-and-fall-of-everedge-global/ |
| 产能 | 不适用；该公司是无形资产咨询机构，而非制造商 | https://m.scoop.co.nz/stories/BU2106/S00260/everedge-capital-acquires-nzs-largest-precision-manufacturer.htm |
| 认证 | 公司专业人员持有多项认证（如CVA、CPVA、RMC、CA），但公司本身是咨询服务机构，而非拥有工业认证的制造商 [中等置信度] | https://www.gobusiness.gov.sg/intellectual-property/ip-grow/everedge-global/ |
| 监管批准 | 不适用;公司提供咨询服务,自身不持有产品的监管批准,但会就此为客户提供建议 | https://www.cfotechoutlook.com/everedge-global, https://www.everedgeglobal.com/case-studies/intangible-asset-strategy-drives-growth/, https://www.gobusiness.gov.sg/intellectual-property/ip-grow/everedge-global/ |
| 生产基地 | 不适用；该公司是一家无形资产咨询公司，但其管理的子公司EverEdge Capital已收购了Accord Precision Limited等制造企业 | https://m.scoop.co.nz/stories/BU2106/S00260/everedge-capital-acquires-nzs-largest-precision-manufacturer.htm |
| 员工人数 | 预估员工人数在1至31人之间 [中等置信度] | https://prospeo.io/c/everedge-global-revenue, https://www.datanyze.com/companies/everedge-global/353498532 |
| 营收 | 预计年收入范围约为$427,775至$5 million [中等置信度] | https://prospeo.io/c/everedge-global-revenue, https://www.datanyze.com/companies/everedge-global/353498532, https://www.everedgeglobal.com/news/everedge-ranks-in-top-500-fastest-growing-firms-in-apac/ |

独立来源: cfotechoutlook.com, datanyze.com, gobusiness.gov.sg, m.scoop.co.nz, nbr.co.nz, prospeo.io

## 技术

- [生物技术知识产权评估](https://cn.bioecon.ru/technology/biotech-ip-valuation/)